M. Murnane

发表

Potent Activity of an Anti-ICAM1 Antibody–Drug Conjugate against Multiple Myeloma

B. Hann, Yang Su, T. Martin, 2020, Clinical Cancer Research.

Cathepsin D protein levels in colorectal tumors: divergent expression patterns suggest complex regulation and function.

John Willett, J. Willett, C. Iacobuzio-Donahue, 2004, International journal of oncology.

Characterizing human colorectal carcinomas by proteolytic profile.

C. Iacobuzio-Donahue, V. Klepeis, M. Murnane, 1997, In vivo.

Active MMP-2 Activity Discriminates Colonic Mucosa, Adenomas with and without High Grade Dysplasia and Cancers

J. Willett, D. McAneny, M. Murnane, 2011 .

δ-Catenin promotes E-cadherin processing and activates β-catenin-mediated signaling: implications on human prostate cancer progression.

Yan Zeng, C. Jung, Q. Lu, 2012, Biochimica et biophysica acta.

Marked increases in cathepsin B and L activities distinguish papillary carcinoma of the thyroid from normal thyroid or thyroid with non‐neoplastic disease

M. Murnane, S. Shuja, Sania Shuja, 1996, International journal of cancer.

Nucleotide Binding Sites and Distant Homology to ras p21 Observed in Thiol Protease Sequences

M. Murnane, 1987 .

Proceedings: Assignment of a locus involved in the expression of hexosaminidase A to chromosome 7 in man.

R. Kucherlapati, F. Ruddle, G. Darlington, 1974, Cytogenetics and Cell Genetics.

Proceedings: Hexosaminidase B: assignment of a locus involved in its expression to chromosome 5 in man.

R. Kucherlapati, F. Ruddle, G. Darlington, 1974, Cytogenetics and cell genetics.

Linkage relationships of seventeen human gene loci as determined by man--mouse somatic cell hybrids.

V. Chapman, F. Ruddle, R. Klebe, 1971, Nature: New biology.

Tay-Sachs' and Sandhoff's diseases: the assignment of genes for hexosaminidase A and B to individual human chromosomes.

R. Kucherlapati, F. Ruddle, G. Darlington, 1975, Proceedings of the National Academy of Sciences of the United States of America.

Presence of activated ras correlates with increased cysteine proteinase activities in human colorectal carcinomas

T. Kuo, Kwonseop Kim, M. Murnane, 1998, International journal of cancer.

Elevations in Cathepsin B Protein Content and Enzyme Activity Occur Independently of Glycosylation during Colorectal Tumor Progression*

C. Iacobuzio-Donahue, M. Murnane, S. Shuja, 1997, The Journal of Biological Chemistry.

Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas

K. Sheahan, M. Murnane, S. Shuja, 1991, International journal of cancer.

Validation of the Hsp 70-Bag 3 Protein-Protein Interaction as a Potential Therapeutic Target in Cancer

J. Weissman, B. Hann, P. Walter, 2014 .

Heterogeneity in the molecular basis of hereditary persistence of fetal haemoglobin

D. Tuan, B. Forget, J. K. Deriel, 1980, Nature.

Isolation and characterization of RNA from snap-frozen tissues and cultured cells

S. Tam, M. Murnane, 1992 .

DNA hypermethylation near the transcription start site of collagen alpha2(I) gene occurs in both cancer cell lines and primary colorectal cancers.

Barbara Smith, Mary Jo Murnane, Kwonseop Kim, 2003, Cancer research.

Content in Human Colorectal Carcinoma Stage-specific Increases in Cathepsin B Messenger RNA Updated

K. Sheahan, M. Ozdemirli, M. Murnane, 2006 .

Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment

Jun O. Liu, J. Taunton, B. Hann, 2017, Haematologica.

Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma.

K. Sheahan, M. Ozdemirli, M. Murnane, 1991, Cancer research.

Active matrix metalloproteinase-2 activity discriminates colonic mucosa, adenomas with and without high-grade dysplasia, and cancers.

J. Willett, D. McAneny, M. Murnane, 2011, Human pathology.

Active MMP‐2 effectively identifies the presence of colorectal cancer

J. Willett, V. Klepeis, D. McAneny, 2009, International journal of cancer.

Cysteine protease activities and tumor development in human colorectal carcinoma.

K. Sheahan, M. Murnane, S. Shuja, 1989, Cancer research.

SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.

L. Notarangelo, J. Puck, K. Sullivan, 2018, Blood.

N‐ras protein: Frequent quantitative and qualitative changes occur in human colorectal carcinomas

Kwonseop Kim, M. Murnane, S. Shuja, 1997, International journal of cancer.

The p97 Inhibitor CB-5083 Is a Unique Disrupter of Protein Homeostasis in Models of Multiple Myeloma

Stephen T. C. Wong, P. L. Bergsagel, C. Mitsiades, 2017, Molecular Cancer Therapeutics.

Cloning and Nucleotide Sequence Analysis of Human Embryonic ζ-Globin cDNA

B. Forget, M. Cohen-Solal, J. K. Deriel, 1982 .

Validation of the Hsp70–Bag3 Protein–Protein Interaction as a Potential Therapeutic Target in Cancer

J. Weissman, B. Hann, P. Walter, 2015, Molecular Cancer Therapeutics.

Human cathepsin B-encoding cDNAs: sequence variations in the 3'-untranslated region.

K. Sheahan, S. Tam, D. Peak, 1994, Gene.

Detection of p21ras mutations in colorectal adenomas and carcinomas by enzyme‐linked immunosorbent assay

W. Carney, Karen A. Johnson, S. Brown-Shimer, 1995, Cancer.

Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas

M. Murnane, M. Murnane, S. Shuja, 2000, British Journal of Cancer.

Cathepsin B activity and protein levels in thyroid carcinoma, Graves' disease, and multinodular goiters.

C. Iacobuzio-Donahue, R. Beazley, C. O'Hara, 1999, Thyroid : official journal of the American Thyroid Association.

Validation of the Hsp70–Bag3 Protein–Protein Interaction as a Potential Therapeutic Target in Cancer

J. Weissman, B. Hann, P. Walter, 2015, Molecular Cancer Therapeutics.